Clinicopathological features, surgical treatments, and survival outcomes of patients with small bowel adenocarcinoma
Shuisheng Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chengfeng Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yingtai Chen(Shanghai Jiao Tong University), Jianwei Zhang(Capital Medical University), Quan Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie Ma(Renal Research Institute), Wei Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Yajie Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Cuiling Zheng(Chinese Academy of Medical Sciences & Peking Union Medical College), Qinglong Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 21
Related Papers
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2021|304
<p>m<sup>6</sup>A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways</p>
|OncoTargets and Therapy|2019|164
Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer
|Theranostics|2022|154
The Risk of Second Cancers After Diagnosis of Primary Thyroid Cancer Is Elevated in Thyroid Microcarcinomas
|Thyroid|2012|102
Thyroid-Stimulating Hormone, Thyroid Hormones, and Risk of Papillary Thyroid Cancer: A Nested Case–Control Study
|Cancer Epidemiology Biomarkers & Prevention|2017|95